{
  "resourceType" : "PlanDefinition",
  "id" : "UntersuchungenWhileTherapieIdelalisib",
  "meta" : {
    "profile" : ["https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/StructureDefinition/recommendation-plan"]
  },
  "text" : {
    "status" : "extensions",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: PlanDefinition UntersuchungenWhileTherapieIdelalisib</b></p><a name=\"UntersuchungenWhileTherapieIdelalisib\"> </a><a name=\"hcUntersuchungenWhileTherapieIdelalisib\"> </a><a name=\"UntersuchungenWhileTherapieIdelalisib-en-US\"> </a><p><b>partOf</b>: <a href=\"PlanDefinition-RecCollectionUntersuchungenVorCLLPlanungOnkoTherapie.html\">Recommendation Collection CLL: Untersuchungen vor Therapieeinleitung (3.11)</a></p><blockquote><p><b>Action Combination Method</b></p><ul><li>method: <span title=\"Codes:{https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/CodeSystem/cs-action-combination-method all}\">All</span></li></ul></blockquote><p><b>knowledgeCapability</b>: computable</p><p><b>knowledgeRepresentationLevel</b>: structured</p><p><b>url</b>: <a href=\"PlanDefinition-UntersuchungenWhileTherapieIdelalisib.html\">PlanDefinition Untersuchung waehrend CLL Therapie mit Idelalisib</a></p><p><b>version</b>: Langversion 2.01</p><p><b>name</b>: UntersuchungenWhileTherapieIdelalisib</p><p><b>title</b>: Untersuchung waehrend CLL Therapie mit Idelalisib</p><p><b>type</b>: <span title=\"Codes:{http://terminology.hl7.org/CodeSystem/plan-definition-type eca-rule}\">ECA Rule</span></p><p><b>status</b>: Active</p><p><b>experimental</b>: false</p><p><b>subject</b>: <a href=\"EvidenceVariable-PopulationCLLOnkoTherapieIdelalisib.html\">Population: CLL onkologische Therapielinie mit Idelalisib Frauen</a></p><p><b>date</b>: 2023-05</p><p><b>publisher</b>: https://www.leitlinienprogramm-onkologie.de/leitlinien/s3-leitlinie-zur-diagnostik-therapie-und-nachsorge-fuer-patienten-mit-einer-chronischen-lymphatischen-leukaemie-cll</p><p><b>description</b>: </p><div><p>regelmäßige Untersuchung waehrend CLL Therapie mit Idelalisib</p>\n</div><h3>Actions</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td><td><b>Definition[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://snomed.info/sct 386053000}\">Evaluation procedure (procedure)</span></td><td><a href=\"ActivityDefinition-CMVPCRCLL.html\">CMV PCR CLL</a></td></tr></table></div>"
  },
  "extension" : [{
    "url" : "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-partOf",
    "valueCanonical" : "https://www.medizin.uni-greifswald.de/fhir/guideline/cll/PlanDefinition/RecCollectionUntersuchungenVorCLLPlanungOnkoTherapie"
  },
  {
    "extension" : [{
      "url" : "method",
      "valueCodeableConcept" : {
        "coding" : [{
          "system" : "https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/CodeSystem/cs-action-combination-method",
          "code" : "all"
        }]
      }
    }],
    "url" : "https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/StructureDefinition/ext-action-combination-method"
  },
  {
    "url" : "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeCapability",
    "valueCode" : "computable"
  },
  {
    "url" : "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeRepresentationLevel",
    "valueCode" : "structured"
  }],
  "url" : "https://www.medizin.uni-greifswald.de/fhir/guideline/cll/PlanDefinition/UntersuchungenWhileTherapieIdelalisib",
  "version" : "Langversion 2.01",
  "name" : "UntersuchungenWhileTherapieIdelalisib",
  "title" : "Untersuchung waehrend CLL Therapie mit Idelalisib",
  "type" : {
    "coding" : [{
      "system" : "http://terminology.hl7.org/CodeSystem/plan-definition-type",
      "code" : "eca-rule"
    }]
  },
  "status" : "active",
  "experimental" : false,
  "subjectCanonical" : "https://www.medizin.uni-greifswald.de/fhir/guideline/cll/EvidenceVariable/PopulationCLLOnkoTherapieIdelalisib",
  "date" : "2023-05",
  "publisher" : "https://www.leitlinienprogramm-onkologie.de/leitlinien/s3-leitlinie-zur-diagnostik-therapie-und-nachsorge-fuer-patienten-mit-einer-chronischen-lymphatischen-leukaemie-cll",
  "description" : "regelmäßige Untersuchung waehrend CLL Therapie mit Idelalisib",
  "action" : [{
    "code" : {
      "coding" : [{
        "system" : "http://snomed.info/sct",
        "code" : "386053000",
        "display" : "Evaluation procedure (procedure)"
      }]
    },
    "definitionCanonical" : "https://www.medizin.uni-greifswald.de/fhir/guideline/cll/ActivityDefinition/CMVPCRCLL"
  }]
}